SOPHiA GENETICS was founded to generate clinically actionable insights from data to improve patient outcomes. Our mission is to provide equal access to knowledge and capabilities by democratizing data-driven medicine. We observed that across the healthcare ecosystem, a vast amount of digital healthcare data was being generated, fueled by technologies such a next-generation sequencing (“NGS”), and which held promise to accelerate the understanding of biology and disease.
Lead Underwriter
Cowen and Company, LLC, Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC
